Fredrik Wiklund, Bright Peak CEO
Versant-backed Bright Peak sets a date to bring its IL-2 into the clinic — but all eyes are on an IPO after latest mega-round drops
Just under a year after securing its first venture round, a Versant-backed startup has pulled in a massive Series B haul to create designer …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
